PT  - JOURNAL ARTICLE
AU  - Buckley, Rita
ED  - Kielgast, Urd
TI  - Liraglutide Reduces Insulin Dose without Affecting Glycemic Control in T1DM
DP  - 2011 Dec 01
TA  - MD Conference Express
PG  - 17--20
VI  - 11
IP  - 11
4099  - http://mdc.sagepub.com/content/11/11/17.short
4100  - http://mdc.sagepub.com/content/11/11/17.full
AB  - This article reports on results from a 4-week randomized, open-label efficacy trial on the effects of treatment with liraglutide, a once-daily human GLP-1 receptor analog, on insulin dose and glycemic control in patients with type 1 diabetes mellitus with and without residual β-cell function [NCT00993720; Kielgast U et al. Diabetes Care 2011].